Silo Pharma Announces Results From IND-Enabling Study Of SP-26 For Fibromyalgia; Shares Move Higher
Silo Pharma, Inc. (NASDAQ:SILO) ("the Company"), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has achieved